Event archive

The number of animal experiments in Germany has been declining for years and more and more alternatives are becoming available. Nevertheless, animal experiments are still unavoidable in many cases and are mandatory in therapy development. After an introductory impulse with an overview of animal experiments in preclinical research and challenges and suggestions for improvement, examples from the development of alternatives will be presented.

Germany's largest biotech event, the German Biotech Days 2024 (Deutsche Biotechnologietage, DBT), will take place on April 16th and 17th in Berlin.

Academic spin-outs play a pivotal role in translating groundbreaking research into innovative products and therapies. However, valuing these emerging ventures presents unique challenges due to their inherent complexities, early-stage development, and intellectual property considerations.

BIO Deutschland's Technology Transfer WG is offering a one-hour digital discussion on the topic of "Fair market value & licensing terms." Participation is free of charge.

mehr…

Anlässlich des World IP Days 2023 geben Vertreter aus Wissenschaft, Industrie sowie dem Deutschen Patent- und Markenamt einen Einblick, welche Rolle der Schutz geistigen Eigentums bei der Erforschung und Kommerzialisierung biotechnologischer Produkte einnimmt.

Germany's largest biotech event, the German Biotechnology Days 2023 (Deutsche Biotechnologietage, DBT), will take place on March 28th and 29th in Wiesbaden. The host region for 2023 is Technologieland Hessen from Wiesbaden, and we were able to win Infectognostics Forschungscampus Jena as another partner region.

With this event, we will give you an overview of the progressive development and dissemination of Liquid Biopsy in the German research and care landscape. It covers the expected areas of application in the coming years and its current clinical availability and presents important companies from Germany that are active in this field.

mehr…

Springer Nature is a global publisher dedicated to providing the best possible service to the whole research community.

mehr…

Lonza recently developed a new accelerated workflow for the development of monoclonal antibodies. As a result, antibody drug product is now available to Lonza’s customer within less than 12 months from DNA sequence availability to IND submission.

mehr…

AGC Biologics is a global CDMO providing pharmaceutical development and manufacturing services for protein-based biologics and cell and gene therapies.

mehr…

AWS offers emerging biotech’s a package of support including promotional credits and technical guidance, so you can take advantage of the latest tools for data management, analytics, machine learning and high-performance computing, all while ensuring the highest level of security, compliance and privacy standards.

mehr…

Germany's largest biotech event, the German Biotechnology Days 2022 (Deutsche Biotechnologietage, DBT), will take place on 4 and 5 May in Hamburg. The host region for 2022 is Life Science Nord Management from Hamburg.

Germany's largest biotech event, the German Biotechnology Days 2021 (Deutsche Biotechnologietage, DBT), will take place on 20th and 21st September in Stuttgart. The host region for 2021 is STERN BioRegion from Stuttgart. As a partner region, we are looking forward to BioLAGO, the network for the health industry in the Lake Constance region.

A considerable part of the global activities for the development and production of diagnostics, vaccines and drugs against Covid-19 takes place at biotech sites in German-speaking countries.

The virtual event combines presentations and partnering. The programme will present German companies that are developing diagnostics, therapies and vaccines against the corona virus. But as the corona pandemic also has a considerable impact on all those companies that are not currently working on coronavirus infection, its prevention and treatment, we would like to have these companies also have their say and report on the current situation.

The 2020 German Biotech Days (DBT) will take place on 27 and 28 May in Wiesbaden. The conference is co-organised by BIO Deutschland and the Council of German BioRegions. This year’s host Bioregion is Hessen Trade & Invest.

The 2019 German Biotech Days (DBT) will take place on 9 and 10 April in Würzburg. The conference is co-organised by BIO Deutschland and the Council of German BioRegions. This year’s host Bioregion is BioM.

One day prior to the biggest national biotech event, the German Biotech Days in Würzburg, we will host the first Investors Day in Germany with a focus on biotech.

The EBDC is a two-day meeting that aims to bring a selected group of 120 business development executives from international pharmaceutical corporations and European biotech companies together with representatives from private equity and venture capital companies.

The EBDC is a two-day meeting that aims to bring a selected group of 120 business development executives from international pharmaceutical corporations and European biotech companies together with representatives from private equity and venture capital companies.